These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7971998)

  • 1. Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex.
    Freudenreich CH; Kreuzer KN
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11007-11. PubMed ID: 7971998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli.
    Huff AC; Leatherwood JK; Kreuzer KN
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1307-11. PubMed ID: 2537494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
    Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
    Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Robinson MJ; Osheroff N
    Biochemistry; 1990 Mar; 29(10):2511-5. PubMed ID: 2159323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the bacteriophage T4 type II DNA topoisomerase that alter sensitivity to antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide and an antibacterial quinolone.
    Freudenreich CH; Chang C; Kreuzer KN
    Cancer Res; 1998 Mar; 58(6):1260-7. PubMed ID: 9515814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
    Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
    Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA.
    Huff AC; Ward RE; Kreuzer KN
    Mol Gen Genet; 1990 Mar; 221(1):27-32. PubMed ID: 2157956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions.
    Ketron AC; Denny WA; Graves DE; Osheroff N
    Biochemistry; 2012 Feb; 51(8):1730-9. PubMed ID: 22304499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases.
    Huff AC; Kreuzer KN
    J Biol Chem; 1990 Nov; 265(33):20496-505. PubMed ID: 2173709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
    Adlakha RC; Ashorn CL; Chan D; Zwelling LA
    Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage of a triple helix-forming oligonucleotide to amsacrine-4-carboxamide derivatives modulates the sequence-selectivity of topoisomerase II-mediated DNA cleavage.
    Arimondo P; Bailly C; Boutorine A; Asseline U; Sun JS; Garestier T; Hélène C
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1205-18. PubMed ID: 11097051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
    Nelson EM; Tewey KM; Liu LF
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1361-5. PubMed ID: 6324188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
    Estey EH; Silberman L; Beran M; Andersson BS; Zwelling LA
    Biochem Biophys Res Commun; 1987 Apr; 144(2):787-93. PubMed ID: 3034264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.
    Yamashita Y; Kawada S; Fujii N; Nakano H
    Biochemistry; 1991 Jun; 30(24):5838-45. PubMed ID: 1646001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
    Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
    Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cleavage complexes using reactive inhibitor derivatives.
    Kreuzer KN; Freudenreich CH; Pommier Y
    Methods Mol Biol; 2001; 95():89-99. PubMed ID: 11089223
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacteriophage T4 mutants hypersensitive to an antitumor agent that induces topoisomerase-DNA cleavage complexes.
    Woodworth DL; Kreuzer KN
    Genetics; 1996 Jul; 143(3):1081-90. PubMed ID: 8807283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.
    Yang L; Rowe TC; Nelson EM; Liu LF
    Cell; 1985 May; 41(1):127-32. PubMed ID: 2986841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of DNA intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-aminoacridines.
    Pommier Y; Covey J; Kerrigan D; Mattes W; Markovits J; Kohn KW
    Biochem Pharmacol; 1987 Oct; 36(20):3477-86. PubMed ID: 2823823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.
    Jensen PB; Sørensen BS; Demant EJ; Sehested M; Jensen PS; Vindeløv L; Hansen HH
    Cancer Res; 1990 Jun; 50(11):3311-6. PubMed ID: 2159380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.